{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:43:00Z","timestamp":1768815780881,"version":"3.49.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006250","name":"Southwest University","doi-asserted-by":"crossref","award":["SWU019039"],"award-info":[{"award-number":["SWU019039"]}],"id":[{"id":"10.13039\/501100006250","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Alterations in the levels of arginine and its related catabolic products (ie, ornithine, citrulline, and argininosuccinate) in the urea and nitric oxide cycles were reported to play roles in the pathogenesis of major depressive disorder (MDD). The aim of this meta-analysis study is to explore the associations between arginine with its related catabolic products and MDD, and to discuss the possible role of arginine catabolism in the pathoetiology of MDD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This study will be conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The English language literature published in the databases of PubMed, EMBASE, PsycINFO and Web of Science will be systematically searched. Forest plots will be used to estimate the associations between arginine and its related catabolic products with MDD. Subgroup analysis and meta-regression will also be performed to investigate the source of the potential heterogeneity. Sensitivity analysis will be performed to strengthen the results and to investigate whether any single study would have a significant effect on the results of meta-analysis. Publication bias will be tested for using the funnel plot with Begg test and Egger test. The Newcastle-Ottawa Scale will be applied to assess the risk of bias of observational studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>An integrated assessment of arginine with its related catabolic products may contribute to predict the risk of MDD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Ethics and dissemination:<\/jats:title>\n            <jats:p>The results of associations between arginine with its related catabolic products and MDD will be reported in a peer-reviewed publication. With our findings from this meta-analysis, we hope to provide the most up-to-date evidence for the contributions of arginine and related catabolic products to predict the risk of MDD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Systematic review registration:<\/jats:title>\n            <jats:p>The protocol of current meta-analysis has been registered at the Open Science Framework [Available at: https:\/\/doi.org\/10.17605\/osf.io\/7fn59].<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021068","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T16:26:44Z","timestamp":1593448004000},"page":"e21068","source":"Crossref","is-referenced-by-count":10,"title":["Association between arginine catabolism and major depressive disorder"],"prefix":"10.1097","volume":"99","author":[{"given":"Bing","family":"Cao","sequence":"first","affiliation":[{"name":"Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education"},{"name":"National Demonstration Center for Experimental Psychology Education, Southwest University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runze","family":"Deng","sequence":"additional","affiliation":[{"name":"Chongqing University Three Gorges Hospital"},{"name":"Chongqing Three Gorges Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongfang","family":"Wang","sequence":"additional","affiliation":[{"name":"Chongqing Blood Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyu","family":"Ren","sequence":"additional","affiliation":[{"name":"College of Physical Education, Southwest University, Chongqing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixin","family":"Xu","sequence":"additional","affiliation":[{"name":"Chongqing University Three Gorges Hospital"},{"name":"Chongqing Three Gorges Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4042-8362","authenticated-orcid":false,"given":"Xiao","family":"Gao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education"},{"name":"National Demonstration Center for Experimental Psychology Education, Southwest University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"R1-20240214","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Disease","year":"2018","journal-title":"Lancet"},{"key":"R2-20240214","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20240214","doi-asserted-by":"crossref","first-page":"e1002090","DOI":"10.1371\/journal.pmed.1002090","article-title":"Genetic and environmental risk for chronic pain and the contribution of risk variants for major depressive disorder: a family-based mixed-model analysis","volume":"13","author":"McIntosh","year":"2016","journal-title":"PLoS Med"},{"key":"R4-20240214","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41398-018-0183-x","article-title":"Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study","volume":"8","author":"Pan","year":"2018","journal-title":"Transl Psychiatry"},{"key":"R5-20240214","doi-asserted-by":"crossref","first-page":"8627","DOI":"10.1073\/pnas.1801609115","article-title":"Acetyl-l-carnitine deficiency in patients with major depressive disorder","volume":"115","author":"Nasca","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R6-20240214","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s12035-018-1051-7","article-title":"Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types i and ii bipolar disorder","volume":"56","author":"Maes","year":"2019","journal-title":"Mol Neurobiol"},{"key":"R7-20240214","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pnpbp.2015.08.016","article-title":"The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder","volume":"65","author":"Maurya","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R8-20240214","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2017.12.030","article-title":"Global arginine bioavailability ratio is decreased in patients with major depressive disorder","volume":"229","author":"Ali-Sisto","year":"2018","journal-title":"J Affect Disord"},{"key":"R9-20240214","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.fsi.2020.01.026","article-title":"Arginine, ornithine and citrulline supplementation in rainbow trout: free amino acid dynamics and gene expression responses to bacterial infection","volume":"98","author":"Clark","year":"2020","journal-title":"Fish Shellfish Immunol"},{"key":"R10-20240214","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3945\/ajcn.112.048025","article-title":"Kinetics of the utilization of dietary arginine for nitric oxide and urea synthesis: insight into the arginine-nitric oxide metabolic system in humans","volume":"97","author":"Mariotti","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"R11-20240214","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.csbj.2016.02.003","article-title":"Metabolomic profiling of post-mortem brain reveals changes in amino acid and glucose metabolism in mental illness compared with controls","volume":"14","author":"Zhang","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"key":"R12-20240214","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00726-010-0797-7","article-title":"A role for PPARalpha in the regulation of arginine metabolism and nitric oxide synthesis","volume":"41","author":"Guelzim","year":"2011","journal-title":"Amino Acids"},{"key":"R13-20240214","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/1440-1681.12826","article-title":"The changes in, and relationship between, plasma nitric oxide and corticotropin-releasing hormone in patients with major depressive disorder","volume":"45","author":"Lu","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R14-20240214","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.pnpbp.2008.08.010","article-title":"Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test","volume":"32","author":"Jesse","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R15-20240214","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/jwh.2009.1551","article-title":"Depressive disorders among cohorts of women veterans with diabetes, heart disease, and hypertension","volume":"19","author":"Shen","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"R16-20240214","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/ijms19061740","article-title":"Classical risk factors and inflammatory biomarkers: one of the missing biological links between cardiovascular disease and major depressive disorder","volume":"19","author":"Baghai","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R17-20240214","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd4623","article-title":"Strategies to increase nitric oxide signalling in cardiovascular disease","volume":"14","author":"Lundberg","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"R18-20240214","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1089\/ars.2012.4614","article-title":"Angiotensin peptides and nitric oxide in cardiovascular disease","volume":"19","author":"Patel","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"R19-20240214","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2012.02.008","article-title":"Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients","volume":"140","author":"Pinto","year":"2012","journal-title":"J Affect Disord"},{"key":"R20-20240214","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.neuroscience.2009.08.029","article-title":"Age-related changes in arginine and its metabolites in memory-associated brain structures","volume":"164","author":"Liu","year":"2009","journal-title":"Neuroscience"},{"key":"R21-20240214","doi-asserted-by":"crossref","first-page":"e894","DOI":"10.1038\/tp.2016.145","article-title":"Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants","volume":"6","author":"Rotroff","year":"2016","journal-title":"Transl Psychiatry"},{"key":"R22-20240214","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s00213-018-4992-7","article-title":"Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects","volume":"235","author":"Moaddel","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"R23-20240214","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R24-20240214","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2018.05.008","article-title":"Leptin and adiponectin levels in major depressive disorder: a systematic review and meta-analysis","volume":"238","author":"Cao","year":"2018","journal-title":"J Affect Disord"},{"key":"R25-20240214","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T16:04:12Z","timestamp":1707926652000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021068"}},"subtitle":["A protocol for the systematic review and meta-analysis of metabolic pathway"],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":25,"journal-issue":{"issue":"27","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021068","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}